5 results match your criteria: "University of Pisa and Azienda Ospedaliera Pisana[Affiliation]"

Objective: This study was designed to test the safety, effectiveness, and costs of off-loading with a novel, off-the-shelf irremovable device in the management of diabetic foot ulceration (DFU).

Research Design And Methods: We prospectively evaluated off-loading of neuropathic plantar ulcers in 40 diabetic outpatients attending our diabetic foot clinic and compared healing rates at the 12-week follow-up, number and severity of adverse events, healing time, costs and applicability of the device, and patients' satisfaction between those randomly assigned to total contact casting (TCC; group A) or to the Optima Diab walker (group B). Deep or infected ulcers were excluded.

View Article and Find Full Text PDF

Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes.

Nutr Metab Cardiovasc Dis

October 2006

Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, University of Pisa and Azienda Ospedaliera Pisana, Ospedale Cisanello, Via Paradisa 2, I-56126 Pisa, Italy.

Background And Aims: Women with previous gestational diabetes (pGDM) are at high risk of developing type 2 diabetes mellitus. The aim of this study was to evaluate insulin action and insulin secretion in women with pGDM.

Methods And Results: One hundred and fifty-three pGDM women and 45 with normal glucose tolerance during pregnancy (controls) were studied 1-3years after delivery.

View Article and Find Full Text PDF

C-reactive protein and metabolic syndrome in women with previous gestational diabetes.

Diabetes Metab Res Rev

February 2007

Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, University of Pisa and Azienda Ospedaliera Pisana, Pisa, Italy.

Background: This study evaluates the presence of metabolic syndrome (MS) and its association with C-reactive protein (CRP) and other cardiovascular (CV) risk factors, in a sample of women with and without previous Gestational Diabetes (pGDM).

Methods: One hundred and sixty-six women with pGDM and 98 women (controls) with uncomplicated pregnancy were studied 16 months after delivery. In all women, plasma glucose, insulin, lipid profile, serum uric acid, C-reactive protein, fibrinogen and homocysteine were measured.

View Article and Find Full Text PDF

Breast MR imaging screening in eight women proved or suspected to be carriers of BRCA1&2 gene mutations.

J Exp Clin Cancer Res

September 2002

Division of Diagnostic and Interventional Radiology, Dept. of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa and Azienda Ospedaliera Pisana, Pisa, Italy.

The aim of this study was to evaluate the efficacy of MR imaging for the early detection of breast tumor in women at high genetic risk compared to conventional strategies such as ultrasonography and mammography. This study included 8 women, 5 of which had undergone surgery for breast cancer. BRCA germ line mutations were detected in 7 women, one patient was enrolled for more than 50% probability to be carrier of BRCA mutation.

View Article and Find Full Text PDF